Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression von Chan, Chia-Hsin, Morrow, John Kenneth, Li, Chien-Feng, Gao, Yuan, Jin, Guoxiang, Moten, Asad, Stagg, Loren J., Ladbury, John E., Cai, Zhen, Xu, Dazhi, Logothetis, Christopher J., Hung, Mien-Chie, Zhang, Shuxing, Lin, Hui-Kuan

Volltext

The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development von Palanisamy, Nallasivam, Yang, Jun, Shepherd, Peter D. A., Li-Ning-Tapia, Elsa M., Labanca, Estefania, Manyam, Ganiraju C., Ravoori, Murali K., Kundra, Vikas, Araujo, John C., Efstathiou, Eleni, Pisters, Louis L., Wan, Xinhai, Wang, Xuemei, Vazquez, Elba S., Aparicio, Ana M., Carskadon, Shannon L., Tomlins, Scott A., Kunju, Lakshmi P., Chinnaiyan, Arul M., Broom, Bradley M., Logothetis, Christopher J., Troncoso, Patricia, Navone, Nora M.

Volltext

Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors von Araujo, John, Logothetis, Christopher

Volltext

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall surviv... von Ryan, Charles J, Prof, Smith, Matthew R, Prof, Fizazi, Karim, Prof, Saad, Fred, Prof, Mulders, Peter F A, Prof, Sternberg, Cora N, MD, Miller, Kurt, Prof, Logothetis, Christopher J, Prof, Shore, Neal D, MD, Small, Eric J, Prof, Carles, Joan, MD, Flaig, Thomas W, MD, Taplin, Mary-Ellen, MD, Higano, Celestia S, Prof, de Souza, Paul, Prof, de Bono, Johann S, Prof, Griffin, Thomas W, MD, De Porre, Peter, MD, Yu, Margaret K, MD, Park, Youn C, PhD, Li, Jinhui, PhD, Kheoh, Thian, PhD, Naini, Vahid, PharmD, Molina, Arturo, MD, Rathkopf, Dana E, MD

Volltext

Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone von EFSTATHIOU, Eleni, TITUS, Mark, TRONCOSO, Patricia, LOGOTHETIS, Christopher T, TSAVACHIDOU, Dimitra, TZELEPI, Vassiliki, SIJIN WEN, HOANG, Anh, MOLINA, Arturo, CHIEFFO, Nicole, SMITH, Lisa A, KARLOU, Maria

Volltext

Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome von Logothetis, Christopher J, Hahn, Andrew W

Volltext

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled... von Fizazi, Karim, Prof Dr, Scher, Howard I, Prof, Molina, Arturo, MD, Logothetis, Christopher J, Prof, Chi, Kim N, MD, Jones, Robert J, PhD, Staffurth, John N, MD, North, Scott, MD, Vogelzang, Nicholas J, MD, Saad, Fred, Prof, Mainwaring, Paul, MD, Harland, Stephen, MD, Goodman, Oscar B, MD, Sternberg, Cora N, MD, Li, Jin Hui, PhD, Kheoh, Thian, PhD, Haqq, Christopher M, MD, de Bono, Johann S, Prof

Volltext

Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer von Efstathiou, Eleni, Titus, Mark, Wen, Sijin, Hoang, Anh, Karlou, Maria, Ashe, Robynne, Tu, Shi Ming, Aparicio, Ana, Troncoso, Patricia, Mohler, James, Logothetis, Christopher J

Volltext

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial von Corn, Paul G, MD, Heath, Elisabeth I, Prof, Zurita, Amado, MD, Ramesh, Naveen, MS, Xiao, Lianchun, MS, Sei, Emi, PhD, Li-Ning-Tapia, Elsa, MD, Tu, Shi-Ming, Prof, Subudhi, Sumit K, MD, Wang, Jennifer, MD, Wang, Xuemei, MS, Efstathiou, Eleni, MD, Thompson, Timothy C, Prof, Troncoso, Patricia, Prof, Navin, Nicholas, PhD, Logothetis, Christopher J, Prof, Aparicio, Ana M, MD

Volltext

Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo’s Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dog... von Logothetis, Christopher J., Hahn, Andrew W.

Volltext

Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers von Aparicio, Ana M, Shen, Li, Tapia, Elsa Li Ning, Lu, Jing-Fang, Chen, Hsiang-Chun, Zhang, Jiexin, Wu, Guanglin, Wang, Xuemei, Troncoso, Patricia, Corn, Paul, Thompson, Timothy C, Broom, Bradley, Baggerly, Keith, Maity, Sankar N, Logothetis, Christopher J

Volltext

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy von Ryan, Charles J, Smith, Matthew R, de Bono, Johann S, Molina, Arturo, Logothetis, Christopher J, de Souza, Paul, Fizazi, Karim, Mainwaring, Paul, Piulats, Josep M, Ng, Siobhan, Carles, Joan, Mulders, Peter F.A, Basch, Ethan, Small, Eric J, Saad, Fred, Schrijvers, Dirk, Van Poppel, Hendrik, Mukherjee, Som D, Suttmann, Henrik, Gerritsen, Winald R, Flaig, Thomas W, George, Daniel J, Yu, Evan Y, Efstathiou, Eleni, Pantuck, Allan, Winquist, Eric, Higano, Celestia S, Taplin, Mary-Ellen, Park, Youn, Kheoh, Thian, Griffin, Thomas, Scher, Howard I, Rathkopf, Dana E

Volltext

VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer von Gao, Jianjun, Ward, John F, Pettaway, Curtis A, Shi, Lewis Z, Subudhi, Sumit K, Vence, Luis M, Zhao, Hao, Chen, Jianfeng, Chen, Hong, Efstathiou, Eleni, Troncoso, Patricia, Allison, James P, Logothetis, Christopher J, Wistuba, Ignacio I, Sepulveda, Manuel A, Sun, Jingjing, Wargo, Jennifer, Blando, Jorge, Sharma, Padmanee

Volltext

Abiraterone and Increased Survival in Metastatic Prostate Cancer von de Bono, Johann S, Logothetis, Christopher J, Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N, Jones, Robert J, Goodman, Oscar B, Saad, Fred, Staffurth, John N, Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W, Hutson, Thomas E, Cheng, Tina, Patterson, Helen, Hainsworth, John D, Ryan, Charles J, Sternberg, Cora N, Ellard, Susan L, Fléchon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M, Scher, Howard I

Volltext

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression von Wang, Guocan, Lu, Xin, Dey, Prasenjit, Deng, Pingna, Wu, Chia Chin, Jiang, Shan, Fang, Zhuangna, Zhao, Kun, Konaparthi, Ramakrishna, Hua, Sujun, Zhang, Jianhua, Li-Ning-Tapia, Elsa M, Kapoor, Avnish, Wu, Chang-Jiun, Patel, Neelay Bhaskar, Guo, Zhenglin, Ramamoorthy, Vandhana, Tieu, Trang N, Heffernan, Tim, Zhao, Di, Shang, Xiaoying, Khadka, Sunada, Hou, Pingping, Hu, Baoli, Jin, Eun-Jung, Yao, Wantong, Pan, Xiaolu, Ding, Zhihu, Shi, Yanxia, Li, Liren, Chang, Qing, Troncoso, Patricia, Logothetis, Christopher J, McArthur, Mark J, Chin, Lynda, Wang, Y Alan, DePinho, Ronald A

Volltext

Osteoblasts in prostate cancer metastasis to bone von Logothetis, Christopher J, Lin, Sue-Hwa

Volltext

PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3 von Salameh, Ahmad, Alessandro K. Lee, Marina Cardó-Vila, Diana N. Nunes, Eleni Efstathiou, Fernanda I. Staquicini, Andrey S. Dobroff, Serena MarchióoÌ, Nora M. Navone, Hitomi Hosoya, Richard C. Lauer, Sijin Wen, Carolina C. Salmeron, Anh Hoang, Irene Newsham, Leandro A. Lima, Dirce M. Carraro, Salvatore Oliviero, Mikhail G. Kolonin, Richard L. Sidman, Kim-Anh Do, Patricia Troncoso, Christopher J. Logothetis, Ricardo R. Brentani, George A. Calin, Webster K. Cavenee, Emmanuel Dias-Neto, Renata Pasqualini, Wadih Arap

Volltext

Improved Outcomes in Men with Advanced Prostate Cancer von Logothetis, Christopher J

Volltext

Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer von APARICIO, Ana M, HARZSTARK, Andrea L, TANNIR, Nizar M, ZURITA, Amado J, MATHEW, Paul, ARAP, Wadih, TRONCOSO, Patricia, THALL, Peter F, LOGOTHETIS, Christopher J, CORN, Paul G, SIJIN WEN, ARAUJO, John C, TU, Shi-Ming, PAGLIARO, Lance C, KIM, Jeri, MILLIKAN, Randall E, RYAN, Charles

Volltext

Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro von Paindelli, Claudia, Navone, Nora, Logothetis, Christopher J., Friedl, Peter, Dondossola, Eleonora

Volltext